Sino Biopharmaceutical Limited (HKG:1177)
7.91
-0.39 (-4.70%)
Aug 27, 2025, 4:08 PM HKT
Sino Biopharmaceutical Revenue
Sino Biopharmaceutical had revenue of 17.57B CNY in the half year ending June 30, 2025, with 23.04% growth. This brings the company's revenue in the last twelve months to 30.57B, up 13.23% year-over-year. In the year 2024, Sino Biopharmaceutical had annual revenue of 28.87B with 10.18% growth.
Revenue (ttm)
30.57B CNY
Revenue Growth
+13.23%
P/S Ratio
4.23
Revenue / Employee
1.25M CNY
Employees
24,379
Market Cap
141.83B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 28.87B | 2.67B | 10.18% |
Dec 31, 2023 | 26.20B | 173.25M | 0.67% |
Dec 31, 2022 | 26.03B | -835.19M | -3.11% |
Dec 31, 2021 | 26.86B | 3.21B | 13.59% |
Dec 31, 2020 | 23.65B | -586.81M | -2.42% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines | 35.81B |
Hansoh Pharmaceutical Group Company | 14.45B |
JD Health International | 71.34B |
Innovent Biologics | 10.03B |
Akeso | 2.26B |
WuXi Biologics | 21.98B |
CSPC Pharmaceutical Group | 28.49B |
Sichuan Kelun-Biotech Biopharmaceutical | 1.64B |
Sino Biopharmaceutical News
- 2 months ago - Hong Kong stocks waver on China’s mixed economic data - South China Morning Post
- 2 months ago - Hong Kong stocks fall slightly on rising geopolitical tensions - South China Morning Post
- 1 year ago - Sino Biopharmaceutical Limited goes ex-dividend tomorrow - Seeking Alpha
- 1 year ago - Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln - Reuters
- 4 years ago - Chinese Company Gets FDA Approval For Drug To Fight Chemotherapy Nausea - Forbes
- 5 years ago - Week In Review: JD Health Raises $3.5 Billion In Hong Kong IPO, Climbs 56% On First Day - Seeking Alpha